

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21377480 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.21377480 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.89733138 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.89733138 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 6.55704392 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.54675092 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.20575658 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.96874327 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.96874327 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.96874327 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95408254 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.72134865 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.63327084 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.56519316 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.50879857 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.44766013 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 5.40014580 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34886192 |
| 19 | urea cycle (GO:0000050) | 5.34591043 |
| 20 | urea metabolic process (GO:0019627) | 5.34591043 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.28940215 |
| 22 | cysteine metabolic process (GO:0006534) | 5.20062949 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.04415918 |
| 24 | protein carboxylation (GO:0018214) | 4.95818711 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95818711 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.94881465 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92100434 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.91934840 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.90948228 |
| 30 | bile acid metabolic process (GO:0008206) | 4.87832119 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.86437251 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.80493960 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.74571592 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.72253461 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.71684619 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.66239866 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.65557179 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.62864832 |
| 39 | lysine metabolic process (GO:0006553) | 4.62048027 |
| 40 | lysine catabolic process (GO:0006554) | 4.62048027 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.56130519 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.56130519 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56130519 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.54189776 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.49471831 |
| 46 | regulation of complement activation (GO:0030449) | 4.48200610 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.48119387 |
| 48 | drug metabolic process (GO:0017144) | 4.46842723 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.41750875 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.41750875 |
| 51 | phospholipid efflux (GO:0033700) | 4.38608827 |
| 52 | heme transport (GO:0015886) | 4.32252328 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.30468601 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.29329960 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.29329960 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.23307696 |
| 57 | cellular glucuronidation (GO:0052695) | 4.22930292 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.19317565 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.18828509 |
| 60 | amine catabolic process (GO:0009310) | 4.18828509 |
| 61 | purine ribonucleotide transport (GO:0015868) | 4.15612741 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.14149762 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.13992481 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.09313266 |
| 65 | ethanol oxidation (GO:0006069) | 4.09083225 |
| 66 | cholesterol efflux (GO:0033344) | 4.01928506 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 3.98158371 |
| 68 | glycine metabolic process (GO:0006544) | 3.96273238 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.95751089 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91720419 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 3.91192482 |
| 72 | acute-phase response (GO:0006953) | 3.89954512 |
| 73 | glutamate metabolic process (GO:0006536) | 3.87869824 |
| 74 | protein activation cascade (GO:0072376) | 3.87824983 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.86864124 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.86520106 |
| 77 | complement activation, classical pathway (GO:0006958) | 3.86496090 |
| 78 | ketone body metabolic process (GO:1902224) | 3.86206228 |
| 79 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.85983137 |
| 80 | response to nitrosative stress (GO:0051409) | 3.82393870 |
| 81 | drug catabolic process (GO:0042737) | 3.81939500 |
| 82 | complement activation (GO:0006956) | 3.80641063 |
| 83 | organic acid catabolic process (GO:0016054) | 3.80431972 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.80431972 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.80291155 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.77891320 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.77891320 |
| 88 | arginine metabolic process (GO:0006525) | 3.75663279 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 3.73933561 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72430572 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.69616484 |
| 92 | fatty acid oxidation (GO:0019395) | 3.69562538 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.67078257 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.66028368 |
| 95 | fibrinolysis (GO:0042730) | 3.65740820 |
| 96 | ethanol metabolic process (GO:0006067) | 3.65171164 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.64636549 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64493897 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64493897 |
| 100 | NAD biosynthetic process (GO:0009435) | 3.63326854 |
| 101 | oxidative demethylation (GO:0070989) | 3.62973446 |
| 102 | lipid oxidation (GO:0034440) | 3.62401307 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.60457054 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59751711 |
| 105 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.59681598 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.59233489 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.58947620 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.58754357 |
| 109 | sterol homeostasis (GO:0055092) | 3.58072650 |
| 110 | serine family amino acid biosynthetic process (GO:0009070) | 3.57792758 |
| 111 | valine metabolic process (GO:0006573) | 3.57789840 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.57219028 |
| 113 | regulation of humoral immune response (GO:0002920) | 3.57077772 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55964167 |
| 115 | cofactor catabolic process (GO:0051187) | 3.55529524 |
| 116 | intestinal absorption (GO:0050892) | 3.53235579 |
| 117 | hormone catabolic process (GO:0042447) | 3.47757023 |
| 118 | alkaloid metabolic process (GO:0009820) | 3.45479667 |
| 119 | negative regulation of blood coagulation (GO:0030195) | 3.41629666 |
| 120 | negative regulation of hemostasis (GO:1900047) | 3.41629666 |
| 121 | regulation of plasminogen activation (GO:0010755) | 3.41614932 |
| 122 | regulation of lipoprotein particle clearance (GO:0010984) | 3.37973053 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.37946238 |
| 124 | cytolysis (GO:0019835) | 3.37581574 |
| 125 | angiotensin maturation (GO:0002003) | 3.31602199 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.31539220 |
| 127 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.29908895 |
| 128 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.24407923 |
| 129 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.24407923 |
| 130 | drug transport (GO:0015893) | 3.23983949 |
| 131 | intestinal cholesterol absorption (GO:0030299) | 3.19133232 |
| 132 | purine nucleotide transport (GO:0015865) | 3.17585764 |
| 133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15277631 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 3.13267285 |
| 135 | diacylglycerol metabolic process (GO:0046339) | 3.12793483 |
| 136 | nucleotide transmembrane transport (GO:1901679) | 3.12661177 |
| 137 | opsonization (GO:0008228) | 3.12562781 |
| 138 | protein-lipid complex subunit organization (GO:0071825) | 3.12298469 |
| 139 | negative regulation of type 2 immune response (GO:0002829) | 3.11429616 |
| 140 | negative regulation of coagulation (GO:0050819) | 3.11093052 |
| 141 | flavonoid metabolic process (GO:0009812) | 3.08959579 |
| 142 | lipoprotein metabolic process (GO:0042157) | 3.05965268 |
| 143 | NADH metabolic process (GO:0006734) | 3.04020437 |
| 144 | phenylpropanoid metabolic process (GO:0009698) | 3.03836255 |
| 145 | nucleoside transmembrane transport (GO:1901642) | 3.02823765 |
| 146 | killing of cells of other organism (GO:0031640) | 3.00804033 |
| 147 | disruption of cells of other organism (GO:0044364) | 3.00804033 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97810331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.98572246 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.86657904 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.68048656 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.25695447 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.10744061 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07391342 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.91199469 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87603028 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77801918 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63918059 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18798947 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04329094 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00468302 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2437127 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96338048 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68885458 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68219349 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63905787 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63410450 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58515718 |
| 21 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56983875 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52933522 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51013834 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48639441 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45282072 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40303549 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38829752 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34946023 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34892115 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34510020 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32737279 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32118100 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30477525 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.27861685 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26841016 |
| 36 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26325356 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23531228 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23015129 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22085294 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18332995 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16935419 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16530838 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15210442 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15135060 |
| 45 | P300_27268052_Chip-Seq_Bcells_Human | 1.13789214 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13002876 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12028943 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10312985 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07729082 |
| 50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07451180 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07301084 |
| 52 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07107475 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06826515 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05812224 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05128342 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04037469 |
| 57 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03779591 |
| 58 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03682887 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03478670 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.03281296 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03005316 |
| 62 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00975711 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00926203 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99091113 |
| 65 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.99009286 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97618483 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97603058 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96436822 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94973543 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94782348 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94710515 |
| 72 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94401674 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92591344 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92306675 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91531122 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91456599 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91064861 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90051976 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89568981 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89514455 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89257962 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87940347 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87700123 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.87565366 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87438766 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83182357 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82709677 |
| 88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82394923 |
| 89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78171666 |
| 90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77527953 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76112688 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75587329 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73733731 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73688669 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73315711 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73223411 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72533467 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70695817 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70387325 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69927943 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67681836 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67681836 |
| 103 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67513494 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66118928 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65668599 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65609021 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65002262 |
| 108 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.64115921 |
| 109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62902704 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61548438 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61399813 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59696984 |
| 113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59370774 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59204890 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.58551975 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.58251677 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.56923021 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.55258143 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.54930698 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54549369 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.54448960 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.53924164 |
| 123 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53061621 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52983833 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52135446 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51621795 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51602078 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50308611 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49896319 |
| 130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48959894 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48605656 |
| 132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48489902 |
| 133 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48023992 |
| 134 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.47770999 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47652333 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47623583 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45978276 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45861874 |
| 139 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45563572 |
| 140 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.45328457 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44375719 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43947254 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43668711 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43519431 |
| 145 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43149786 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.42099514 |
| 147 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.41789098 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41337930 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41298830 |
| 150 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.41217754 |
| 151 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.41217754 |
| 152 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41090168 |
| 153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40573866 |
| 154 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.39554824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.80731040 |
| 2 | MP0005360_urolithiasis | 7.26028018 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13245468 |
| 4 | MP0005365_abnormal_bile_salt | 6.05929330 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03757143 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.79260220 |
| 7 | MP0003252_abnormal_bile_duct | 3.75983425 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51102998 |
| 9 | MP0009840_abnormal_foam_cell | 3.07608532 |
| 10 | MP0005083_abnormal_biliary_tract | 2.85266132 |
| 11 | MP0003195_calcinosis | 2.75947300 |
| 12 | MP0005332_abnormal_amino_acid | 2.75011726 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.68881454 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.48104741 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.21497780 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.12289285 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11468480 |
| 18 | MP0000609_abnormal_liver_physiology | 2.11163461 |
| 19 | MP0003303_peritoneal_inflammation | 2.08482658 |
| 20 | MP0003868_abnormal_feces_composition | 1.97943554 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.84232083 |
| 22 | MP0001764_abnormal_homeostasis | 1.80082957 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.73235857 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.68509127 |
| 25 | MP0005451_abnormal_body_composition | 1.61115391 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57918643 |
| 27 | MP0009697_abnormal_copulation | 1.57622835 |
| 28 | MP0005025_abnormal_response_to | 1.49463643 |
| 29 | MP0003186_abnormal_redox_activity | 1.46227728 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.42369379 |
| 31 | MP0005670_abnormal_white_adipose | 1.40094605 |
| 32 | MP0005671_abnormal_response_to | 1.28910230 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.28673846 |
| 34 | MP0002419_abnormal_innate_immunity | 1.23638898 |
| 35 | MP0000858_altered_metastatic_potential | 1.23206992 |
| 36 | MP0003011_delayed_dark_adaptation | 1.20238699 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.19369869 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.19330239 |
| 39 | MP0005647_abnormal_sex_gland | 1.16766635 |
| 40 | MP0009764_decreased_sensitivity_to | 1.16564884 |
| 41 | MP0001873_stomach_inflammation | 1.16190155 |
| 42 | MP0000685_abnormal_immune_system | 1.15705359 |
| 43 | MP0001800_abnormal_humoral_immune | 1.15405473 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.15213211 |
| 45 | MP0000598_abnormal_liver_morphology | 1.11326072 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.07312836 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.05145321 |
| 48 | MP0002254_reproductive_system_inflammat | 1.04116041 |
| 49 | MP0009763_increased_sensitivity_to | 1.02629054 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.02245671 |
| 51 | MP0002723_abnormal_immune_serum | 1.01869280 |
| 52 | MP0001790_abnormal_immune_system | 0.99879422 |
| 53 | MP0005387_immune_system_phenotype | 0.99879422 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.98644308 |
| 55 | MP0004130_abnormal_muscle_cell | 0.98276292 |
| 56 | MP0008469_abnormal_protein_level | 0.96235955 |
| 57 | MP0001663_abnormal_digestive_system | 0.92747280 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 0.91385972 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.90392561 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 0.89998615 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.89978183 |
| 62 | MP0002971_abnormal_brown_adipose | 0.88708626 |
| 63 | MP0001851_eye_inflammation | 0.87911726 |
| 64 | MP0005408_hypopigmentation | 0.86172909 |
| 65 | MP0003724_increased_susceptibility_to | 0.85497579 |
| 66 | MP0000490_abnormal_crypts_of | 0.85293744 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.84850640 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.83399646 |
| 69 | MP0005334_abnormal_fat_pad | 0.82609014 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 0.82431476 |
| 71 | MP0002452_abnormal_antigen_presenting | 0.82024484 |
| 72 | MP0002148_abnormal_hypersensitivity_rea | 0.81421159 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.80960997 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.80754867 |
| 75 | MP0003866_abnormal_defecation | 0.79828700 |
| 76 | MP0001819_abnormal_immune_cell | 0.78642520 |
| 77 | MP0002420_abnormal_adaptive_immunity | 0.78013128 |
| 78 | MP0000604_amyloidosis | 0.77601388 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.77426545 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.77391853 |
| 81 | MP0005535_abnormal_body_temperature | 0.76886537 |
| 82 | MP0003879_abnormal_hair_cell | 0.76776998 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.75016583 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.69332615 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.68324370 |
| 86 | MP0001756_abnormal_urination | 0.68188418 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.67605093 |
| 88 | MP0003690_abnormal_glial_cell | 0.63931241 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.63651115 |
| 90 | MP0005266_abnormal_metabolism | 0.63646571 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.63582757 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.63582757 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.63541483 |
| 94 | MP0004947_skin_inflammation | 0.61962297 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.60508480 |
| 96 | MP0009278_abnormal_bone_marrow | 0.59980312 |
| 97 | MP0005448_abnormal_energy_balance | 0.59812642 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.59733251 |
| 99 | MP0002405_respiratory_system_inflammati | 0.57984837 |
| 100 | MP0000716_abnormal_immune_system | 0.57961138 |
| 101 | MP0001661_extended_life_span | 0.57944815 |
| 102 | MP0004381_abnormal_hair_follicle | 0.56066927 |
| 103 | MP0002132_abnormal_respiratory_system | 0.52632982 |
| 104 | MP0004043_abnormal_pH_regulation | 0.51718696 |
| 105 | MP0003436_decreased_susceptibility_to | 0.50411811 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.48682423 |
| 107 | MP0001853_heart_inflammation | 0.48086570 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.47584658 |
| 109 | MP0003953_abnormal_hormone_level | 0.47535111 |
| 110 | MP0009115_abnormal_fat_cell | 0.47232748 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.46372604 |
| 112 | MP0002928_abnormal_bile_duct | 0.45230773 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.44811341 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.43787266 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.42108178 |
| 116 | MP0005395_other_phenotype | 0.40902609 |
| 117 | MP0008873_increased_physiological_sensi | 0.39997360 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.39984000 |
| 119 | MP0000566_synostosis | 0.39241230 |
| 120 | MP0006082_CNS_inflammation | 0.38797578 |
| 121 | MP0009053_abnormal_anal_canal | 0.37608198 |
| 122 | MP0000249_abnormal_blood_vessel | 0.37339508 |
| 123 | MP0002970_abnormal_white_adipose | 0.36812485 |
| 124 | MP0005166_decreased_susceptibility_to | 0.36708997 |
| 125 | MP0008874_decreased_physiological_sensi | 0.35281594 |
| 126 | MP0004147_increased_porphyrin_level | 0.35138890 |
| 127 | MP0000579_abnormal_nail_morphology | 0.34956748 |
| 128 | MP0008872_abnormal_physiological_respon | 0.34329701 |
| 129 | MP0003075_altered_response_to | 0.33879991 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.33169823 |
| 131 | MP0009785_altered_susceptibility_to | 0.32276253 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.32232367 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.32129975 |
| 134 | MP0002822_catalepsy | 0.32021281 |
| 135 | MP0002168_other_aberrant_phenotype | 0.31224364 |
| 136 | MP0001881_abnormal_mammary_gland | 0.30945749 |
| 137 | MP0003718_maternal_effect | 0.29962668 |
| 138 | MP0003300_gastrointestinal_ulcer | 0.29701502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05615836 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.71601309 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.69233812 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.19475574 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.18006564 |
| 6 | Xanthomatosis (HP:0000991) | 5.87600768 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.72157030 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30876477 |
| 9 | Complement deficiency (HP:0004431) | 4.83709913 |
| 10 | Joint hemorrhage (HP:0005261) | 4.75135436 |
| 11 | Hyperammonemia (HP:0001987) | 4.57537989 |
| 12 | Ketosis (HP:0001946) | 4.44246995 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.42606208 |
| 14 | Hyperglycinemia (HP:0002154) | 4.35986841 |
| 15 | Hyperglycinuria (HP:0003108) | 4.30646750 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.22334988 |
| 17 | Epidermoid cyst (HP:0200040) | 4.19302390 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17427628 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14693712 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08728682 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.08728682 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06179903 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.03501154 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.02351697 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00754177 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.99986425 |
| 27 | Fat malabsorption (HP:0002630) | 3.93649826 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.87065816 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83219444 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69843896 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62913096 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55095707 |
| 33 | Abnormality of complement system (HP:0005339) | 3.50891373 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.48161779 |
| 35 | Ketoacidosis (HP:0001993) | 3.37569319 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.26648333 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.26302226 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11844749 |
| 39 | Nephritis (HP:0000123) | 3.09799294 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.08758749 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.05582783 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.05582783 |
| 43 | Metabolic acidosis (HP:0001942) | 3.00088599 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.99784466 |
| 45 | Steatorrhea (HP:0002570) | 2.96988718 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.92413601 |
| 47 | Purpura (HP:0000979) | 2.91319815 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.90219270 |
| 49 | Myocardial infarction (HP:0001658) | 2.88455170 |
| 50 | Vascular calcification (HP:0004934) | 2.88403991 |
| 51 | Lethargy (HP:0001254) | 2.77235081 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.77178497 |
| 53 | Renal cortical cysts (HP:0000803) | 2.68294554 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.67675217 |
| 55 | Cerebral edema (HP:0002181) | 2.64858598 |
| 56 | Spontaneous abortion (HP:0005268) | 2.61743864 |
| 57 | Megaloblastic anemia (HP:0001889) | 2.60259459 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.58690589 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.56256212 |
| 60 | Gout (HP:0001997) | 2.55732164 |
| 61 | Increased serum ferritin (HP:0003281) | 2.53090846 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.52443290 |
| 63 | Joint swelling (HP:0001386) | 2.47250143 |
| 64 | Skin nodule (HP:0200036) | 2.44743488 |
| 65 | Pancreatitis (HP:0001733) | 2.41062499 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.39743640 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.36741269 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.36059003 |
| 69 | Orchitis (HP:0100796) | 2.33266891 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.33227316 |
| 71 | Menorrhagia (HP:0000132) | 2.30126923 |
| 72 | Myositis (HP:0100614) | 2.28475488 |
| 73 | Gingival bleeding (HP:0000225) | 2.26673179 |
| 74 | Acanthocytosis (HP:0001927) | 2.26419948 |
| 75 | Glomerulonephritis (HP:0000099) | 2.26377636 |
| 76 | Hypochromic anemia (HP:0001931) | 2.26311113 |
| 77 | Vomiting (HP:0002013) | 2.26247264 |
| 78 | Amyloidosis (HP:0011034) | 2.25565762 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25040969 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.24884053 |
| 81 | Increased IgM level (HP:0003496) | 2.24443855 |
| 82 | Mitral stenosis (HP:0001718) | 2.24292711 |
| 83 | Anorexia (HP:0002039) | 2.24078306 |
| 84 | Enlarged kidneys (HP:0000105) | 2.21603543 |
| 85 | Proximal tubulopathy (HP:0000114) | 2.21167733 |
| 86 | Pulmonary embolism (HP:0002204) | 2.20277084 |
| 87 | Irritability (HP:0000737) | 2.15872219 |
| 88 | Esophageal varix (HP:0002040) | 2.15265168 |
| 89 | Cholelithiasis (HP:0001081) | 2.15249832 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11331108 |
| 91 | Neonatal onset (HP:0003623) | 2.11190907 |
| 92 | Late onset (HP:0003584) | 2.10050049 |
| 93 | Cheilitis (HP:0100825) | 2.09753456 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.09511003 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 2.09511003 |
| 96 | Brushfield spots (HP:0001088) | 2.09279677 |
| 97 | Spastic diplegia (HP:0001264) | 2.07694755 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.07219315 |
| 99 | Opisthotonus (HP:0002179) | 2.06940406 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06919786 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 2.04146328 |
| 102 | Optic neuritis (HP:0100653) | 2.04146328 |
| 103 | Malnutrition (HP:0004395) | 2.02900310 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.01569394 |
| 105 | Glycosuria (HP:0003076) | 2.01569394 |
| 106 | Alkalosis (HP:0001948) | 2.00296946 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.97624119 |
| 108 | Chronic diarrhea (HP:0002028) | 1.96124445 |
| 109 | Thrombophlebitis (HP:0004418) | 1.96122528 |
| 110 | Encephalitis (HP:0002383) | 1.92262401 |
| 111 | Widely patent fontanelles and sutures (HP:0004492) | 1.91925517 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88888444 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.88876452 |
| 114 | Nausea (HP:0002018) | 1.88598785 |
| 115 | Rickets (HP:0002748) | 1.88181653 |
| 116 | Increased purine levels (HP:0004368) | 1.86420207 |
| 117 | Hyperuricemia (HP:0002149) | 1.86420207 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85393538 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85393538 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85393538 |
| 121 | Hyperglycemia (HP:0003074) | 1.85333139 |
| 122 | Epistaxis (HP:0000421) | 1.84525311 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.84332850 |
| 124 | Poikilocytosis (HP:0004447) | 1.83607960 |
| 125 | Cerebral palsy (HP:0100021) | 1.82814768 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 1.81250803 |
| 127 | Symptomatic seizures (HP:0011145) | 1.80530943 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80377766 |
| 129 | Pigmentary retinal degeneration (HP:0001146) | 1.79910050 |
| 130 | Hypertriglyceridemia (HP:0002155) | 1.79260159 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.77793015 |
| 132 | Gingivitis (HP:0000230) | 1.76492264 |
| 133 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75740293 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.73430266 |
| 135 | Hypophosphatemia (HP:0002148) | 1.72356558 |
| 136 | Meningitis (HP:0001287) | 1.72169291 |
| 137 | Hyperphosphaturia (HP:0003109) | 1.69207265 |
| 138 | Nasal polyposis (HP:0100582) | 1.68598420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.84971055 |
| 2 | ERN1 | 4.03182218 |
| 3 | FGFR4 | 4.02841418 |
| 4 | SIK1 | 3.62562591 |
| 5 | INSRR | 3.52522984 |
| 6 | TAOK3 | 2.92320439 |
| 7 | RIPK4 | 2.42904246 |
| 8 | FRK | 2.08108537 |
| 9 | FLT3 | 1.95774059 |
| 10 | PRPF4B | 1.82672920 |
| 11 | IRAK3 | 1.82074433 |
| 12 | PKN2 | 1.81824517 |
| 13 | MST1R | 1.81474772 |
| 14 | TYK2 | 1.75414709 |
| 15 | TLK1 | 1.74173173 |
| 16 | ERBB4 | 1.71337133 |
| 17 | SMG1 | 1.66764130 |
| 18 | ACVR1B | 1.60906341 |
| 19 | MAPK11 | 1.59208429 |
| 20 | MAP3K14 | 1.54648511 |
| 21 | MAP3K7 | 1.48456545 |
| 22 | TESK2 | 1.47960161 |
| 23 | PIK3CG | 1.46831706 |
| 24 | TRIB3 | 1.41961111 |
| 25 | PRKG2 | 1.40078621 |
| 26 | TIE1 | 1.39901847 |
| 27 | MAP2K4 | 1.38951060 |
| 28 | EPHA2 | 1.35858967 |
| 29 | NEK9 | 1.34729323 |
| 30 | PTK6 | 1.33285323 |
| 31 | PRKAA2 | 1.27989923 |
| 32 | BLK | 1.22304671 |
| 33 | PINK1 | 1.20205669 |
| 34 | EPHB1 | 1.19836454 |
| 35 | MAPK15 | 1.16844236 |
| 36 | MAP3K3 | 1.16572622 |
| 37 | IKBKE | 1.16216821 |
| 38 | JAK1 | 1.16165756 |
| 39 | MAP2K3 | 1.15027974 |
| 40 | TNK2 | 1.12116462 |
| 41 | EPHA3 | 1.10772910 |
| 42 | JAK2 | 1.10479854 |
| 43 | TBK1 | 1.09529381 |
| 44 | STK39 | 1.09175108 |
| 45 | FGR | 1.08170621 |
| 46 | FGFR2 | 1.06652015 |
| 47 | LCK | 1.04958787 |
| 48 | TGFBR2 | 1.02346536 |
| 49 | PRKD2 | 0.99843063 |
| 50 | STK38L | 0.99713984 |
| 51 | TAOK1 | 0.97145610 |
| 52 | MYLK | 0.95459459 |
| 53 | CAMK1D | 0.95315127 |
| 54 | CDC42BPA | 0.95097214 |
| 55 | IRAK1 | 0.94196456 |
| 56 | LATS1 | 0.92662037 |
| 57 | NME2 | 0.91172644 |
| 58 | GRK6 | 0.89155823 |
| 59 | SGK2 | 0.85904377 |
| 60 | MAP2K6 | 0.85483163 |
| 61 | ICK | 0.85433199 |
| 62 | SYK | 0.85235164 |
| 63 | MATK | 0.84041769 |
| 64 | MAP2K2 | 0.83157911 |
| 65 | LYN | 0.82764771 |
| 66 | CSK | 0.82615582 |
| 67 | MAPK4 | 0.81284764 |
| 68 | HCK | 0.80729638 |
| 69 | ABL2 | 0.79216436 |
| 70 | SGK3 | 0.78273344 |
| 71 | KDR | 0.77998462 |
| 72 | GRK1 | 0.77592835 |
| 73 | IRAK4 | 0.75973903 |
| 74 | NLK | 0.74706095 |
| 75 | FGFR1 | 0.74059078 |
| 76 | MAP4K1 | 0.73838987 |
| 77 | DAPK2 | 0.73232173 |
| 78 | ERBB2 | 0.72752615 |
| 79 | PIM1 | 0.72549428 |
| 80 | PRKCQ | 0.69490731 |
| 81 | PIM2 | 0.69001840 |
| 82 | IRAK2 | 0.68894285 |
| 83 | ZAP70 | 0.66365378 |
| 84 | MAPK7 | 0.66232946 |
| 85 | JAK3 | 0.66076467 |
| 86 | FGFR3 | 0.64748413 |
| 87 | PRKCZ | 0.63782624 |
| 88 | PIK3CA | 0.63359172 |
| 89 | PRKAA1 | 0.62486076 |
| 90 | MAPK12 | 0.62386019 |
| 91 | RPS6KA2 | 0.61219814 |
| 92 | GRK7 | 0.59165465 |
| 93 | RPS6KC1 | 0.58287757 |
| 94 | RPS6KL1 | 0.58287757 |
| 95 | PRKACG | 0.57449616 |
| 96 | SGK494 | 0.56138502 |
| 97 | SGK223 | 0.56138502 |
| 98 | FES | 0.55831734 |
| 99 | CDK6 | 0.55779901 |
| 100 | LRRK2 | 0.54628818 |
| 101 | PAK4 | 0.54083386 |
| 102 | MAP3K13 | 0.53666147 |
| 103 | CSF1R | 0.53179841 |
| 104 | BTK | 0.52864206 |
| 105 | TAOK2 | 0.52613247 |
| 106 | RPS6KA6 | 0.51999000 |
| 107 | STK10 | 0.51686467 |
| 108 | RET | 0.51133617 |
| 109 | CAMK4 | 0.50302185 |
| 110 | GSK3A | 0.50273097 |
| 111 | DDR2 | 0.50092647 |
| 112 | WNK4 | 0.49131150 |
| 113 | MET | 0.48432962 |
| 114 | CAMK2G | 0.48361766 |
| 115 | PDPK1 | 0.48198103 |
| 116 | RIPK1 | 0.48068783 |
| 117 | KIT | 0.47101690 |
| 118 | NUAK1 | 0.45680575 |
| 119 | BMPR2 | 0.45338935 |
| 120 | LMTK2 | 0.45309645 |
| 121 | PDK2 | 0.45250356 |
| 122 | AKT3 | 0.44212559 |
| 123 | CHUK | 0.43717231 |
| 124 | TXK | 0.43586000 |
| 125 | ITK | 0.41787234 |
| 126 | HIPK2 | 0.40652209 |
| 127 | SRC | 0.38436927 |
| 128 | PTK2B | 0.38398116 |
| 129 | IKBKB | 0.37489968 |
| 130 | CDK4 | 0.37482089 |
| 131 | FYN | 0.37207906 |
| 132 | TEC | 0.37029784 |
| 133 | MAP2K1 | 0.37000380 |
| 134 | DYRK1B | 0.36528219 |
| 135 | IGF1R | 0.36440247 |
| 136 | MAP3K5 | 0.36335112 |
| 137 | PDK3 | 0.35769345 |
| 138 | PDK4 | 0.35769345 |
| 139 | CAMK1G | 0.34718941 |
| 140 | PDK1 | 0.33371862 |
| 141 | MAP3K11 | 0.33103965 |
| 142 | PKN1 | 0.30645930 |
| 143 | MAP3K1 | 0.29630479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20029875 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33346794 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.08064753 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08025629 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83272332 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69823725 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67614477 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61614039 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61512024 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59485104 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54005295 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42328447 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34306100 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24330013 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23215808 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.18764898 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18154443 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99686981 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98841162 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96374546 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95587693 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93870121 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88566171 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80786758 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78262820 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68505875 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68350273 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67708436 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67612772 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67402762 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66047947 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60236213 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55239859 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50663467 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50607123 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50500382 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46027257 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41461801 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.38457964 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36999979 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35588301 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.30643104 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.30609824 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25884476 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20211626 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19290047 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14006839 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13650295 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09271480 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06615986 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04827297 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04372071 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01318251 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00388679 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97546708 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93593249 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93479282 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.93095976 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.85040264 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82286850 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81163827 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76022765 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74342623 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73445351 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68644295 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.65245867 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64956109 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60837989 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57013174 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56787714 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53344368 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50768859 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41472881 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40506068 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38002585 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36321686 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35729652 |
| 78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.35235891 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35031846 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33129837 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.31445237 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29750041 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28996637 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27709513 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26546291 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25759856 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25335713 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.23633505 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.18814583 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18804493 |
| 91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.17682610 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17552421 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14145601 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06271230 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05678247 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03019890 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01254843 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00077455 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2188663 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2172583 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2143224 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2056050 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2044120 |
| 104 | Pertussis_Homo sapiens_hsa05133 | -0.1991723 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1945337 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1943856 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1790734 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1573281 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1525283 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1439227 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1340838 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0858377 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.0710154 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0666038 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0586823 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0017366 |

